Global Canine Oral Chewable Tablets Market by Composition Type (Botanically synthesized, Chemically synthesized), by Drug Class (Analgesics, Anti-infective, Anti-ulcers, Vitamins & minerals, Cardiovascular drugs, Others), by Application (Gastrointestinal diseases, Cardiovascular disorders, Infectious diseases, Nutritional supplements, Others), by Product Type (Prescription, Over the Counter (OTC)), by Distribution Channel (Veterinary clinics, Veterinary Pharmacies, Online veterinary stores, Others) and Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Canine Oral Chewable Tablets Market are the oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and fleas infections, and among others. Various additives and flavouring agents are used in the formulation of canine oral chewable tablets for masking the unpleasant taste and odour of the drugs. The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately. The global canine oral chewable tablets market is in the developing stage as several local and international players are actively engaged in the manufacturing of canine oral chewable tablets for the treatment of chronic canine diseases. Acquisitions and mergers, collaborations, joint ventures, and product launches, are some key strategies followed by the manufacturers for increasing their share in the global market. For instance, in December 2015, Boehringer Ingelheim acquired Merial (Sanofi animal health) for strengthening its product portfolio. In addition, in May 2014, Merck Animal Health received the FDA approval for its drug Bravecto (fluralaner) used in the treatment of fleas and ticks infections. Moreover, in December 2014, Putney, Inc. launched the Carprofen canine oral chewable tablets for the treatment of pain and inflammation.

Global Canine Oral Chewable Tablets Market Summary

Study Period

2023-29

Base Year

2022

CAGR

X%

Largest Market

Asia-Pacific

Fastest Growing Market

North America
Canine Oral Chewable Tablets Market Dynamics

Rise in the expenditure in animal welfare and wellness, wider availability of the canine oral chewable tablets in the market, and rise in the prevalence of various canine diseases such as tick and fleas infections, anticipated to fuel the global market over the forecast period. In addition, ease of administration of tablets compared with parenteral formulations, lack of nutrition values in the canine feed, and initiations taken by various pet organizations and NGOs for animal welfare are expected bolster the canine oral chewable tablets market over the forecast years. However, stringent regulatory policies for the approval of veterinary formulations, lack of awareness about the canine oral chewable tablets in rural areas, high cost of the products, and withdrawn of drugs from the market such as levothyroxine sodium due to FDA warning regarding the lack of approval might hinder the global market growth in the coming future.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Canine Oral Chewable Tablets Market Segmentation

composition type
  • Botanically synthesized
  • Chemically synthesized
Drugs Type
By Application
  • Gastrointestinal diseases
  • Cardiovascular disorders
  • Infectious diseases
  • Nutritional supplements
  • Others
Distribution Channel
  • Veterinary clinics
  • Veterinary Pharmacies
  • Online veterinary stores
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive summary 2. Global Canine Oral Chewable Tablets Market Introduction 2.1. Global Canine Oral Chewable Tablets Market– Taxonomy 2.2. Global Canine Oral Chewable Tablets Market–Definitions 2.2.1. Composition Type 2.2.2. Drug Class 3. Global Canine Oral Chewable Tablets Market Dynamics 3.1. Drivers 3.2. Restraints 3.3. Opportunities/Unmet Needs of the Market 3.4. Trends 3.5. Global Canine Oral Chewable Tablets Market Dynamics – Factors Impact Analysis 3.6. Global Canine Oral Chewable Tablets Market– Recent Market Introductions 4. Global Canine Oral Chewable Tablets Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 4.3. Market Oppurtunity Analysis 5. Global Canine Oral Chewable Tablets Market Forecast, By Composition Type, 2013 - 2017 and Forecast, 2018 - 2024 5.1. Botanically Synthesized 5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.3. Market Opportunity Analysis 5.2. Chemically Synthesized 5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.2.3. Market Opportunity Analysis 6. Global Canine Oral Chewable Tablets Market Forecast, By Drug Class, 2013 - 2017 and Forecast, 2018 - 2024 6.1. Analgesics 6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.1.3. Market Opportunity Analysis 6.2. Anti-infective 6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.2.3. Market Opportunity Analysis 6.3. Anti-ulcers 6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.3.3. Market Opportunity Analysis 6.4. Vitamins & Minerals 6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.4.3. Market Opportunity Analysis 6.5. Cardiovascular Drugs 6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.5.3. Market Opportunity Analysis 6.6. Others 6.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.6.3. Market Opportunity Analysis 7. Global Canine Oral Chewable Tablets Market Forecast, By Application, 2013 - 2017 and Forecast, 2018 - 2024 7.1. Gastrointestinal Diseases 7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.1.3. Market Opportunity Analysis 7.2. Cardiovascular Disorders 7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.2.3. Market Opportunity Analysis 7.3. Cardiovascular Disorders 7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.3.3. Market Opportunity Analysis 7.4. Cardiovascular Disorders 7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.4.3. Market Opportunity Analysis 7.5. Others 7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.5.3. Market Opportunity Analysis 8. Global Canine Oral Chewable Tablets Market Forecast, By Distribution Channel, 2013 - 2017 and Forecast, 2018 - 2024 8.1. Veterinary Clinics 8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.1.3. Market Opportunity Analysis 8.2. Veterinary Pharmacies 8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.2.3. Market Opportunity Analysis 8.3. Online Veterinary Pharmacies 8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.3.3. Market Opportunity Analysis 8.4. Others 8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.4.3. Market Opportunity Analysis 9. Global Canine Oral Chewable Tablets Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024 9.1. North America 9.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.1.3. Market Opportunity Analysis 9.2. Europe 9.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.2.3. Market Opportunity Analysis 9.3. Asia-Pacific 9.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.3.3. Market Opportunity Analysis 9.4. Latin America 9.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.4.3. Market Opportunity Analysis 9.5. Middle East and Africa 9.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.5.3. Market Opportunity Analysis 9.6. Global Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Region, 2018 – 2024 10. North America Canine Oral Chewable Tablets Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 10.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.1.1. Botanically Synthesized 10.1.2. Chemically Synthesized 10.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.2.1. Analgesics 10.2.2. Anti-infective 10.2.3. Anti-ulcers 10.2.4. Vitamins & Minerals 10.2.5. Cardiovascular Drugs 10.2.6. Others 10.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.3.1. Gastrointestinal Diseases 10.3.2. Cardiovascular Disorders 10.3.3. Infectious Diseases 10.3.4. Nutritional Supplements 10.3.5. Others 10.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.4.1. Veterinary Clinics 10.4.2. Veterinary Pharmacies 10.4.3. Online Veterinary Pharmacies 10.4.4. Others 10.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 10.5.1. U.S. 10.5.2. Canada 10.6. North America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024 10.7. North America Canine Oral Chewable Tablets Market Dynamics – Trends 11. Europe Canine Oral Chewable Tablets Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 11.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.1.1. Botanically Synthesized 11.1.2. Chemically Synthesized 11.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.2.1. Analgesics 11.2.2. Anti-infective 11.2.3. Anti-ulcers 11.2.4. Vitamins & Minerals 11.2.5. Cardiovascular Drugs 11.2.6. Others 11.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.3.1. Gastrointestinal Diseases 11.3.2. Cardiovascular Disorders 11.3.3. Infectious Diseases 11.3.4. Nutritional Supplements 11.3.5. Others 11.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.4.1. Veterinary Clinics 11.4.2. Veterinary Pharmacies 11.4.3. Online Veterinary Pharmacies 11.4.4. Others 11.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.5.1. Germany 11.5.2. UK 11.5.3. France 11.5.4. Spain 11.5.5. Italy 11.5.6. Russia 11.5.7. Poland 11.5.8. Rest of Europe 11.6. Europe Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024 11.7. Europe Canine Oral Chewable Tablets Market Dynamics – Trends 12. Asia-Pacific Canine Oral Chewable Tablets Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 12.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.1.1. Botanically Synthesized 12.1.2. Chemically Synthesized 12.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.2.1. Analgesics 12.2.2. Anti-infective 12.2.3. Anti-ulcers 12.2.4. Vitamins & Minerals 12.2.5. Cardiovascular Drugs 12.2.6. Others 12.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.3.1. Gastrointestinal Diseases 12.3.2. Cardiovascular Disorders 12.3.3. Infectious Diseases 12.3.4. Nutritional Supplements 12.3.5. Others 12.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.4.1. Veterinary Clinics 12.4.2. Veterinary Pharmacies 12.4.3. Online Veterinary Pharmacies 12.4.4. Others 12.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 12.5.1. Japan 12.5.2. China 12.5.3. India 12.5.4. ASEAN 12.5.5. Australia & New Zealand 12.5.6. Rest of Asia-Pacific 12.6. Asia-Pacific Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024 12.7. Asia-Pacific Canine Oral Chewable Tablets Market Dynamics – Trends 13. Latin America Canine Oral Chewable Tablets Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 13.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.1.1. Botanically Synthesized 13.1.2. Chemically Synthesized 13.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.2.1. Analgesics 13.2.2. Anti-infective 13.2.3. Anti-ulcers 13.2.4. Vitamins & Minerals 13.2.5. Cardiovascular Drugs 13.2.6. Others 13.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.3.1. Gastrointestinal Diseases 13.3.2. Cardiovascular Disorders 13.3.3. Infectious Diseases 13.3.4. Nutritional Supplements 13.3.5. Others 13.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.4.1. Veterinary Clinics 13.4.2. Veterinary Pharmacies 13.4.3. Online Veterinary Pharmacies 13.4.4. Others 13.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Argentina 13.5.4. Venezuela 13.5.5. Rest of Latin America 13.6. Latin America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024 13.7. Latin America Canine Oral Chewable Tablets Market Dynamics – Trends 14. Middle East & Africa Canine Oral Chewable Tablets Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 14.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.1.1. Botanically Synthesized 14.1.2. Chemically Synthesized 14.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.2.1. Analgesics 14.2.2. Anti-infective 14.2.3. Anti-ulcers 14.2.4. Vitamins & Minerals 14.2.5. Cardiovascular Drugs 14.2.6. Others 14.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.3.1. Gastrointestinal Diseases 14.3.2. Cardiovascular Disorders 14.3.3. Infectious Diseases 14.3.4. Nutritional Supplements 14.3.5. Others 14.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.4.1. Veterinary Clinics 14.4.2. Veterinary Pharmacies 14.4.3. Online Veterinary Pharmacies 14.4.4. Others 14.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 14.5.1. Gulf Cooperation Council (GCC) Countries 14.5.2. Israel 14.5.3. South Africa 14.5.4. Rest of MEA 14.6. MEA Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024 14.7. MEA Canine Oral Chewable Tablets Market Dynamics – Trends 15. Competition Landscape 15.1. Strategic Dashboard of Top Market Players 15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis) 15.2.1. Zoetis, Inc. (Pfizer) (U.S) 15.2.2. Virbac AH Inc. (France) 15.2.3. Elanco (Eli Lilly and Co.) (U.S.) 15.2.4. Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany) 15.2.5. Pala-Tech Laboratories (U.S.) 15.2.6. Bayer HealthCare LLC, (Bayer AG) (Germany) 15.2.7. Merck Animal Health (Merck &co. Inc.) (U.S.) 15.2.8. Putney, Inc. (Dechra Pharmaceuticals) (U.K.) 16. Research Methodology 17. Key Assumptions and Acronyms
  • Zoetis, Inc. (Pfizer) (U.S)
  • Virbac AH Inc. (France)
  • Elanco (Eli Lilly and Co.) (U.S.)
  • Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)
  • Pala-Tech Laboratories (U.S.)
  • Bayer HealthCare LLC, (Bayer AG) (Germany)
  • Merck Animal Health (Merck &co. Inc.) (U.S.)
  • Putney, Inc. (Dechra Pharmaceuticals) (U.K.)